FPH.NZ - Fisher & Paykel Healthcare Corporation Limited

NZSE - NZSE Delayed price. Currency in NZD
15.00
-0.05 (-0.33%)
At close: 4:59PM NZST
Stock chart is not supported by your current browser
Previous close15.05
Open14.99
Bid0.00 x 485800
Ask0.00 x 241000
Day's range14.95 - 15.04
52-week range10.81 - 15.15
Volume2,653,167
Avg. volume829,113
Market cap8.567B
Beta1.44
PE ratio (TTM)45.45
EPS (TTM)0.33
Earnings date21 May 2018 - 25 May 2018
Forward dividend & yield0.35 (23,148.00%)
Ex-dividend date2018-06-21
1y target est12.48
  • June Fundamental Stock Pick: Fisher & Paykel Healthcare Corporation Limited (NZE:FPH)
    Simply Wall St.15 hours ago

    June Fundamental Stock Pick: Fisher & Paykel Healthcare Corporation Limited (NZE:FPH)

    Building up an investment case requires looking at a stock holistically. Today I’ve chosen to put the spotlight on Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) due to its excellentRead More...

  • AAP7 months ago

    Fisher & Paykel wins patent court case

    Fisher & Paykel Healthcare has won a patent case against rival medical products manufacturer ResMed, after a court in the United Kingdom ruled the patent claim invalid. In 2016, New Zealand-based Fisher & Paykel sought a declaration from the High Court that three of ResMed's European patents were invalid in the UK and should be revoked. ResMed revoked two of its patents in the UK just before the trial was due to start, but left one for consideration by the High Court's patents division.

  • We're sorry, but this is all we were able to find on this topic.